The Anticariogenic Effect of Miswak (Silvadora Persica) and Grape Seed Extract
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nasr City
-
Cairo, Nasr City, Egypt
- Al Azhar University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with high caries risk
- Males or females
- Medically free patients
- Patients approving to participate in the study
Exclusion Criteria:
- Patients who were on antibiotic therapy or corticosteroid therapy for 30 days before the examination
- Patients had history of professional cleaning in the last 15 days
- Patients with exposed pulp
- Evidence of parafunctional habits
- Patients with developmental dental anomalies
- Patients undergoing or will start orthodontic treatment
- Patients with removable prosthesis
- Periapical Abscess or Fistula
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Miswak
Miswak sticks used twice daily, every 12 hours, for three months.
|
sticks
Other Names:
|
|
Experimental: Grape Seed Extract
Grape seed extract 6.5% mouthwash used twice daily, every 12 hours, for three months.
|
Mouthwash
Other Names:
|
|
Active Comparator: Fluoride Mouthwash
0.05% fluoride mouthwash used twice daily, every 12 hours, for three months.
|
mouthwash
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
quantitative measure of the change in salivary streptococcus mutans Count from baseline to one month and three months.
Time Frame: Baseline, one month, three months.
|
the patients used the treatments twice daily for three months.
unstimulated saliva samples were collected from the patients at baseline,after one month and after three months.
Every time samples were incubated with Mitiis Salivaris with Bacitricin and 20% sucrose for streptococcus mutans count.
|
Baseline, one month, three months.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
quantitative measure of the change in saliva buffering capacity from baseline to one month and three months.
Time Frame: baseline, one month , three months
|
the patients used the treatments twice daily for three months.
unstimulated saliva samples were collected from the patients at baseline, after one month and after three months.
each time, saliva buffering capacity was measured using Hand Held pH meter and 0.1 mol/l hydrochloric acid that was titrated to the tested saliva.
|
baseline, one month , three months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Maha Niazy, professor, Al-Azhar University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Tooth Demineralization
- Tooth Diseases
- Dental Caries
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Antineoplastic Agents
- Protective Agents
- Antineoplastic Agents, Phytogenic
- Antiprotozoal Agents
- Antiparasitic Agents
- Antioxidants
- Cariostatic Agents
- Fluorides
- Sodium Fluoride
- Proanthocyanidin
- Grape Seed Extract
Other Study ID Numbers
Other Study ID Numbers
- REC17-082
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.